KCM Investment Advisors LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,431 shares of the healthcare conglomerate's stock after selling 8,049 shares during the quarter. KCM Investment Advisors LLC's holdings in UnitedHealth Group were worth $6,288,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. Wallace Capital Management Inc. increased its position in UnitedHealth Group by 0.9% during the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate's stock valued at $1,239,000 after buying an additional 19 shares in the last quarter. Western Pacific Wealth Management LP grew its holdings in shares of UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after buying an additional 19 shares during the last quarter. MCF Advisors LLC raised its stake in UnitedHealth Group by 0.8% in the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after acquiring an additional 20 shares during the last quarter. Axiom Financial Strategies LLC grew its stake in UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock valued at $291,000 after purchasing an additional 20 shares during the last quarter. Finally, Richwood Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares during the period. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Stock Up 1.7 %
NYSE UNH traded up $9.45 during mid-day trading on Wednesday, reaching $562.53. 4,126,898 shares of the company's stock traded hands, compared to its average volume of 4,297,612. The company has a market cap of $514.55 billion, a price-to-earnings ratio of 36.28, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a fifty day simple moving average of $509.40 and a 200-day simple moving average of $541.42. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the business earned $5.83 EPS. The firm's revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 54.19%.
Insider Activity at UnitedHealth Group
In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.
Analysts Set New Price Targets
A number of brokerages recently issued reports on UNH. Piper Sandler lowered their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, Mizuho increased their target price on UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research note on Wednesday. Twenty-one research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $630.35.
View Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.